ABNORMAL EXTRACELLULAR-MATRIX IN EHLERS-DANLOS SYNDROME TYPE-IV DUE TO THE SUBSTITUTION OF GLYCINE-934 BY GLUTAMIC-ACID IN THE TRIPLE-HELICAL DOMAIN OF TYPE-III COLLAGEN
J. Mcgrory et al., ABNORMAL EXTRACELLULAR-MATRIX IN EHLERS-DANLOS SYNDROME TYPE-IV DUE TO THE SUBSTITUTION OF GLYCINE-934 BY GLUTAMIC-ACID IN THE TRIPLE-HELICAL DOMAIN OF TYPE-III COLLAGEN, Clinical genetics, 50(6), 1996, pp. 442-445
A unique substitution of glycine 934 by glutamic acid in the triple he
lical domain of type III collagen was identified in a proband with Ehl
ers-Danlos syndrome type IV. The substitution was due to the transitio
n of G 3302 to A in alpha 1(III) cDNA which is encoded by exon 46 of C
OL3A1. It resulted in a severe deficiency of type III collagen in fibr
oblast cultures and dermis. Dilatation of the endoplasmic reticulum of
the dermal fibroblasts was probably due to the failure of these cells
to secrete type III collagen molecules containing one or more mutant
alpha 1(III) chains. The dermal collagen fibrils were narrow, but thei
r constituent type III collagen molecules contained predominantly norm
al alpha 1(III) chains. As a result, the major effect of the substitut
ion of glycine 934 by glutamic acid was to severely reduce the amount
of normal type III collagen available for the formation of heterotypic
collagen fibrils in the extracellular matrix.